OTCMKTS:NPHC - Nutra Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0003 0.00 (0.00 %) (As of 02/20/2019 04:00 PM ET)Previous Close$0.0003Today's Range$0.0003 - $0.000352-Week Range$0.0001 - $0.0048Volume2.00 million shsAverage Volume4.63 million shsMarket Capitalization$599,998.80P/E RatioN/ADividend YieldN/ABeta6.11 ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida. Receive NPHC News and Ratings via Email Sign-up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NPHC Previous Symbol CUSIPN/A Webwww.nutrapharma.com Phone954-509-0911Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.03Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$120,000.00 Price / Sales5.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,020,000.00 Net Margins-4,741.67% Return on EquityN/A Return on Assets-1,740.23%Miscellaneous Employees4 Outstanding Shares1,999,996,000Market Cap$599,998.80 OptionableNot Optionable Nutra Pharma (OTCMKTS:NPHC) Frequently Asked Questions What is Nutra Pharma's stock symbol? Nutra Pharma trades on the OTCMKTS under the ticker symbol "NPHC." How were Nutra Pharma's earnings last quarter? Nutra Pharma Corp. (OTCMKTS:NPHC) posted its quarterly earnings data on Friday, August, 17th. The company reported $0.00 earnings per share for the quarter. The firm earned $0.03 million during the quarter. View Nutra Pharma's Earnings History. Has Nutra Pharma been receiving favorable news coverage? News articles about NPHC stock have been trending neutral on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nutra Pharma earned a daily sentiment score of 0.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the near future. Who are some of Nutra Pharma's key competitors? Some companies that are related to Nutra Pharma include True Drinks (TRUU), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE), Beleave (BE) and ImmuDyne (IMMD). Who are Nutra Pharma's key executives? Nutra Pharma's management team includes the folowing people: Mr. Erik J. Deitsch, Chairman, CEO, Pres & CFO (Age 51)Dr. Dale VanderPutten, Chief Scientific Officer (Age 60)Mr. Neil Roth, Pres of Designer Diagnostics, IncMs. Nina Goldstein, Sec. (Age 59)Major General Kenneth Dowd, Strategic Advisor How do I buy shares of Nutra Pharma? Shares of NPHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nutra Pharma's stock price today? One share of NPHC stock can currently be purchased for approximately $0.0003. How big of a company is Nutra Pharma? Nutra Pharma has a market capitalization of $599,998.80 and generates $120,000.00 in revenue each year. Nutra Pharma employs 4 workers across the globe. What is Nutra Pharma's official website? The official website for Nutra Pharma is http://www.nutrapharma.com. How can I contact Nutra Pharma? Nutra Pharma's mailing address is 12538 WEST ATLANTIC BLVD., CORAL SPRINGS FL, 33071. The company can be reached via phone at 954-509-0911 or via email at [email protected] MarketBeat Community Rating for Nutra Pharma (OTCMKTS NPHC)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 59 (Vote Outperform)Underperform Votes: 40 (Vote Underperform)Total Votes: 99MarketBeat's community ratings are surveys of what our community members think about Nutra Pharma and other stocks. Vote "Outperform" if you believe NPHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NPHC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: What are defining characteristics of a correction?